Emerging Diseases News

A meta-analysis of three trials assessing the use of SGLT2 inhibitors for inpatients with COVID-19 showed the drug class did not reduce risk for death or other outcomes compared with usual care or placebo, but was safe.

If given to patients with early and symptomatic COVID-19, treatment with remdesivir can accelerate the rate of viral clearance in oropharyngeal swabs over 1 week, researchers found.

CDC advisors will meet next month to vote on recommendations for the updated COVID-19 vaccines that are expected to be available in the United States this fall, according to a notice published Friday in the Federal Register.

Distinguishing between long COVID and fibromyalgia has challenged health care providers across specialties, but rheumatologists may be positioned to clearly define both conditions and offer patients much-needed relief and respect.

Certain new-onset inflammatory rheumatic diseases, including polymyalgia rheumatica and vasculitis, may be triggered by SARS-CoV-2 infection or vaccination against COVID-19, according to data published in RMD Open.

The FDA expanded its approval of Gilead Sciences’ antiviral, Veklury, for the treatment of COVID-19 in patients with mild, moderate and severe hepatic impairment, without requiring dose adjustments, according to a manufacturer release.

A 3-month-old girl is diagnosed with severe thrush resistant to treatment, along with persistent cutaneous rash, thought to be flaring episodes of candidiasis that never quite clear. What's your diagnosis?

A study of more than 30,000 hospitalized children with SARS-CoV-2 infection found that ICU admissions for COVID-19 decreased over the course of the pandemic but ventilatory and oxygen support for the youngest children did not.

Novavax on Tuesday said its updated COVID-19 vaccine candidate induced neutralizing antibodies against emerging SARS-CoV-2 subvariants in small animal and non-human primate studies.

Why am I hooked on ID? It’s a great question! It might sound clichéd, but my love for this specialty grew as I turned 10.